Conference Coverage: ASCO 2023 – Focus on Lung Cancer

Expert perspectives and strategic insights on the latest therapeutic developments and translational research in lung cancer treatment

June 16, 2023
Corey Langer MD Scientific Leader Faculty Chair Aptitude Health

Faculty Chair

Corey J. Langer, MD, FACP

University of Pennsylvania, Philadelphia, PA, USA


Enriqueta Felip, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain

Marina Garassino, MD
National Cancer Institute of Milan, Italy

Roy Herbst, MD, PhD
Yale Cancer Center, New Haven, CT,  USA

Benjamin Besse, MD, PhD
Institute Gustave Roussy, Villejuif, France

Solange Peters, MD, PhD
University of Lausanne, Switzerland

Lynette Sholl, MD
Dana-Farber Cancer Institute, Boston, MA, USA

Mark Socinski, MD
AdventHealth Cancer Institute, Orlando, FL, USA


Download the meeting agenda

View Agenda

Sample Report

Start discovering the insights

View Report


  • Immunotherapy in Stage I–III NSCLC
  • Immunotherapy in Stage IV NSCLC
  • EGFR (common mutations): Resectable and Metastatic
  • EGFR (exon 20 and other uncommon mutations)
  • Oncogenic Fusions
  • Oncogenic Mutations
  • Other Targets in NSCLC/SCLC

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.